Insider Selling: Sera Prognostics, Inc. (NASDAQ:SERA) Insider Sells 4,078 Shares of Stock

Sera Prognostics, Inc. (NASDAQ:SERA) insider Paul Kearney sold 4,078 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $7.32, for a total value of $29,850.96. Following the sale, the insider now directly owns 176,889 shares in the company, valued at $1,294,827.48. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Sera Prognostics Stock Performance

Sera Prognostics stock traded down $0.20 during trading on Tuesday, reaching $7.24. 79,534 shares of the company’s stock were exchanged, compared to its average volume of 175,932. The company’s 50-day moving average is $7.41 and its two-hundred day moving average is $7.68. Sera Prognostics, Inc. has a 52-week low of $1.65 and a 52-week high of $12.35. The firm has a market cap of $241.59 million, a price-to-earnings ratio of -7.31 and a beta of 1.04.

Sera Prognostics (NASDAQ:SERA) last posted its quarterly earnings data on Wednesday, November 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.02). The firm had revenue of $0.03 million for the quarter, compared to analyst estimates of $0.09 million. During the same period in the previous year, the business earned ($0.23) EPS. Analysts anticipate that Sera Prognostics, Inc. will post -0.95 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. RA Capital Management L.P. bought a new position in Sera Prognostics in the 1st quarter worth approximately $18,420,000. AWM Investment Company Inc. grew its holdings in shares of Sera Prognostics by 56.0% during the 1st quarter. AWM Investment Company Inc. now owns 584,664 shares of the company’s stock worth $5,320,000 after purchasing an additional 209,762 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Sera Prognostics by 100.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 150,708 shares of the company’s stock worth $892,000 after purchasing an additional 75,441 shares in the last quarter. Ballentine Partners LLC acquired a new stake in shares of Sera Prognostics during the 2nd quarter worth approximately $294,000. Finally, Twelve Points Wealth Management LLC acquired a new stake in shares of Sera Prognostics during the 2nd quarter worth approximately $257,000. 54.64% of the stock is owned by institutional investors.

Sera Prognostics Company Profile

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.